CA
NZ
UK
AU
IND
US
● No confirmed company-specific release was identified for the session.
● No confirmed company-specific news was identified for the session.
● The confirmed record shows no company-specific release tied to Insmed for the session.
● Jaguar Health surged with no company-specific news, press release or filing found to explain the move.
● Johnson & Johnson finished as the third-worst Dow performer, with no company-specific news behind the move.
● The trial enrolled 4,047 adults and compared VAX-31 with Pfizer's Prevnar 20 and Merck's Capvaxive.
● PDS Biotechnology rocketed with aMarket Valueof about $54.2 million, firmly in micro-cap territory.
● QTREX Quantum rocketed after already jumping in premarket trading, extending gains through the session.
● Sunshine Biopharma plunged with no press release, filing, trial update or financing announcement found to explain it.
● The FDA approved a secondManufacturingsuite for Alvotech's SIMLANDI, its biosimilar to AbbVie's Humira.
Please wait processing your request...